DNA Vaccines: Their formulations, engineering and delivery
M Kozak, J Hu - Vaccines, 2024 - mdpi.com
The concept of DNA vaccination was introduced in the early 1990s. Since then,
advancements in the augmentation of the immunogenicity of DNA vaccines have brought …
advancements in the augmentation of the immunogenicity of DNA vaccines have brought …
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Simple Summary Cancer treatments have made remarkable advances with the introduction
of immunotherapy, which recruits the body's immune system to fight cancer. Despite these …
of immunotherapy, which recruits the body's immune system to fight cancer. Despite these …
Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas
D Fernando, AU Ahmed, BRG Williams - Frontiers in Oncology, 2024 - frontiersin.org
Pediatric high-grade gliomas (pHGG) are a rare yet devastating malignancy of the central
nervous system's glial support cells, affecting children, adolescents, and young adults …
nervous system's glial support cells, affecting children, adolescents, and young adults …
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens
KJ Fuchs, M van de Meent, MW Honders, I Khatri… - Blood, 2024 - ashpublications.org
Allogeneic stem cell transplantation (alloSCT) is a curative treatment for hematological
malignancies. After HLA-matched alloSCT, antitumor immunity is caused by donor T cells …
malignancies. After HLA-matched alloSCT, antitumor immunity is caused by donor T cells …
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Simple Summary Cancer immune evasion poses a significant challenge in developing
effective cancer treatments. The interplay between the immune system and tumors …
effective cancer treatments. The interplay between the immune system and tumors …
[HTML][HTML] Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture
Background Human papillomavirus (HPV)-negative head and neck squamous cell
carcinoma (HNSCC) remains a treatment-resistance disease with limited response to …
carcinoma (HNSCC) remains a treatment-resistance disease with limited response to …
The effects of anti-lung cancer in nude mice by a fully human single-chain antibody against associated antigen Ts7TMR between A549 cells and Trichinella spiralis
T Yue, J Wang, F Liu, P Gong, J Li… - Artificial Cells …, 2024 - Taylor & Francis
Lung cancer is a dangerous disease that is lacking in an ideal therapy. Here, we evaluated
the anti-lung cancer effect in nude mice of a fully human single-chain antibody (scFv) …
the anti-lung cancer effect in nude mice of a fully human single-chain antibody (scFv) …
Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer
Z Chaudhry, A Boyadzhyan, K Sasaninia, V Rai - Antibodies, 2024 - mdpi.com
As one of the most prevalent forms of cancer worldwide, breast cancer has garnered
significant attention within the clinical research setting. While traditional treatment employs a …
significant attention within the clinical research setting. While traditional treatment employs a …
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
T Katopodi, S Petanidis, D Anestakis, C Charalampidis… - Pharmaceutics, 2023 - mdpi.com
Following its therapeutic effect in hematological metastasis, chimeric antigen receptor (CAR)
T cell therapy has gained a great deal of attention during the last years. However, the …
T cell therapy has gained a great deal of attention during the last years. However, the …
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma
C Los, S Klobuch, JBAG Haanen - The Cancer Journal, 2024 - journals.lww.com
Major progress in prolonging survival of patients with advanced melanoma has been made
in the past decade because of the development and approval of immune checkpoint …
in the past decade because of the development and approval of immune checkpoint …